| Net Cash Provided by (Used in) Operating Activities |
$43,181,000 |
USD |
-16% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$54,160,000 |
USD |
203% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$84,759,000 |
USD |
-14% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
70,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
35,805,089 |
shares |
7.8% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$12,582,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$11,314,000 |
USD |
185% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$15,567,000 |
USD |
1.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$73,732,000 |
USD |
-9.2% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$109,889,000 |
USD |
23% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$4,453,548,000 |
USD |
9.4% |
Q3 2024 |
Q3 2024 |
| Deferred Income Tax Expense (Benefit) |
$3,020,000 |
USD |
365% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$4,093,000 |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$29,631,000 |
USD |
2.4% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$5,906,000 |
USD |
8.4% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$69,853,000 |
USD |
12% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |